Tesamorelin 15mg Dosage Protocol

1. Preparation and Measurement

Tesamorelin 15mg With 1.5mL of Diluent

Add 1.5mL of bacteriostatic water to the vial. The resulting concentration is 10mg/mL. On a U-100 syringe, each unit contains 100mcg.

Preparation

1. Draw 1.5mL of bacteriostatic water using sterile equipment.
2. Let the liquid run slowly down the inside wall of the vial.
3. Gently swirl until dissolved. Do not shake.
4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in the approved comparator formulation. Frequency: once daily.

Vial estimate: One 15mg vial contains approximately 10 documented-size administrations at 1.4mg.

Practical Notes

• The table applies only to this vial prepared with exactly 1.5mL.
• Record the amount, date, and preparation used.

3. Supplies Needed

• Tesamorelin 15mg vial.
• 1.5mL of bacteriostatic water per vial.
• Sterile U-100 syringes.
• Alcohol swabs.
• Sharps container.

4. Storage and Handling

• Keep unopened vials cool, dry, dark, and protected from moisture.
• After preparation, refrigerate at 2-8 degrees C.
• Protect from light and avoid repeated freeze-thaw cycles.
• Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Tesamorelin is the active molecule in an approved prescription product for a specific indication. The current approved formulation uses a formulation-specific 1.4mg daily amount and preparation method.

The table uses that amount only as a comparator. A laboratory vial is not the approved product, and its preparation instructions must not be assumed equivalent to the prescription formulation.

Primary Research and Regulatory References

1. FDA EGRIFTA SV prescribing information
2. Tesamorelin randomized clinical trial